UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms

American journal of physiology. Regulatory, integrative and comparative physiology, 2015-12, Vol.309 (11), p.R1326-R1343

2015

Volltextzugriff (PDF)

Placental Ischemia Says "NO" to Proper NOS-Mediated Control of Vascular Tone and Blood Pressure in Preeclampsia

International journal of molecular sciences, 2021-10, Vol.22 (20), p.11261

2021

Volltextzugriff (PDF)

Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia

Hypertension (Dallas, Tex. 1979), 2008-08, Vol.52 (2), p.402-407

2008

Volltextzugriff (PDF)

Sildenafil attenuates placental ischemia-induced hypertension

American journal of physiology. Regulatory, integrative and comparative physiology, 2013-08, Vol.305 (4), p.R397-R403

2013

Volltextzugriff (PDF)

Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes

International journal of molecular sciences, 2021-01, Vol.22 (2), p.564

2021

Volltextzugriff (PDF)

Reduced uterine perfusion pressure induces hypertension in the pregnant mouse

American journal of physiology. Regulatory, integrative and comparative physiology, 2014-12, Vol.307 (11), p.R1353-R1357

2014

Volltextzugriff (PDF)

Immune Mechanisms Linking Obesity and Preeclampsia

Biomolecules (Basel, Switzerland), 2015-11, Vol.5 (4), p.3142-3176

2015

Volltextzugriff (PDF)

Functional polymorphisms of NOS3 and GUCY1A3 affect both nitric oxide formation and association with hypertensive disorders of pregnancy

Frontiers in genetics, 2024-02, Vol.15, p.1293082

2024

Volltextzugriff (PDF)

Cell-free DNA as a potential biomarker for preeclampsia

Expert review of molecular diagnostics, 2021-12, Vol.21 (12), p.1253-1256

Palei, Ana C.

2021

Volltextzugriff (PDF)

Antihypertensive therapy responsiveness and adverse outcomes in preeclampsia: insights into molecular mechanisms underlying cardiovascular and renal complications

Frontiers in pharmacology, 2023, Vol.14, p.1281382-1281382

2023

Volltextzugriff (PDF)

Increased NOS coupling by the metabolite tetrahydrobiopterin (BH4) reduces preeclampsia/IUGR consequences

Redox biology, 2022-09, Vol.55, p.102406, Article 102406

2022

Volltextzugriff (PDF)

Plasma eNOS Concentration in Healthy Pregnancy and in Hypertensive Disorders of Pregnancy: Evidence of Reduced Concentrations in Pre-Eclampsia from Two Independent Studies

Diseases, 2023-11, Vol.11 (4), p.155

2023

Volltextzugriff (PDF)

Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension

Molecular human reproduction, 2009-02, Vol.15 (2), p.115-120

2009

Volltextzugriff (PDF)

Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia

Molecular human reproduction, 2010-07, Vol.16 (7), p.506-510

2010

Volltextzugriff (PDF)

Sustained Elevated Circulating Activin A Impairs Global Longitudinal Strain in Pregnant Rats: A Potential Mechanism for Preeclampsia-Related Cardiac Dysfunction

Cells (Basel, Switzerland), 2022-02, Vol.11 (4), p.742

2022

Volltextzugriff (PDF)

Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy

Experimental and molecular pathology, 2012-04, Vol.92 (2), p.217-221

2012

Volltextzugriff (PDF)

Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre‐eclampsia

Journal of cellular and molecular medicine, 2013-10, Vol.17 (10), p.1300-1307

2013

Volltextzugriff (PDF)

The Potential Role of Visfatin in Mediating Vascular Dysfunction and Hypertension

Journal of cardiovascular pharmacology, 2023-11, Vol.82 (5), p.347

2023

Volltextzugriff (PDF)

Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers

European journal of clinical pharmacology, 2011-04, Vol.67 (4), p.365-370

2011

Volltextzugriff (PDF)

Effects of Matrix Metalloproteinase (MMP)-2 Polymorphisms on Responsiveness to Antihypertensive Therapy of Women with Hypertensive Disorders of Pregnancy

Basic & clinical pharmacology & toxicology, 2012-10, Vol.111 (4), p.262-267

2012

Volltextzugriff (PDF)

Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin

International Journal of Hypertension, 2012-01, Vol.2012, p.486053-6

2012

Volltextzugriff (PDF)

Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine

European journal of pharmacology, 2010-02, Vol.627 (1), p.216-222

2010

Volltextzugriff (PDF)

Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions

Clinical chemistry and laboratory medicine, 2009-07, Vol.47 (7), p.888-891

2009

Volltextzugriff (PDF)

Vitamin D receptor polymorphisms in hypertensive disorders of pregnancy

Molecular biology reports, 2012-12, Vol.39 (12), p.10903-10906

2012

Volltextzugriff (PDF)

Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity

Clinical biochemistry, 2011-08, Vol.44 (12), p.1012-1014

2011

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(81)

Sprache

Englisch
(81)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms

Placental Ischemia Says "NO" to Proper NOS-Mediated Control of Vascular Tone and Blood Pressure in Preeclampsia

Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia

Sildenafil attenuates placental ischemia-induced hypertension

Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes

Reduced uterine perfusion pressure induces hypertension in the pregnant mouse

Immune Mechanisms Linking Obesity and Preeclampsia

Functional polymorphisms of NOS3 and GUCY1A3 affect both nitric oxide formation and association with hypertensive disorders of pregnancy

Cell-free DNA as a potential biomarker for preeclampsia

Antihypertensive therapy responsiveness and adverse outcomes in preeclampsia: insights into molecular mechanisms underlying cardiovascular and renal complications

Increased NOS coupling by the metabolite tetrahydrobiopterin (BH4) reduces preeclampsia/IUGR consequences

Plasma eNOS Concentration in Healthy Pregnancy and in Hypertensive Disorders of Pregnancy: Evidence of Reduced Concentrations in Pre-Eclampsia from Two Independent Studies

Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension

Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia

Sustained Elevated Circulating Activin A Impairs Global Longitudinal Strain in Pregnant Rats: A Potential Mechanism for Preeclampsia-Related Cardiac Dysfunction

Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy

Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre‐eclampsia

The Potential Role of Visfatin in Mediating Vascular Dysfunction and Hypertension

Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers

Effects of Matrix Metalloproteinase (MMP)-2 Polymorphisms on Responsiveness to Antihypertensive Therapy of Women with Hypertensive Disorders of Pregnancy

Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin

Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine

Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions

Vitamin D receptor polymorphisms in hypertensive disorders of pregnancy

Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity

Suchergebnisse filtern